GLP1R and pulmonary fibrosis: Taken all together these potent effects of GLP-1 in lung architecture, function and pathophysiology, the GLP-1R agonist family of peptides became a promising candidate to be tested as potential therapeutic agents in pulmonary fibrosis, once shown they are able to modulate many of the mechanisms underlying the pathophysiology of this disease.